A new severe respiratory syndrome caused by a coronavirus was first observed in Wuhan (China) in December 2019. The infection has spread all over the world, and consequently, on March 2020, the disease was declared a pandemic by the WHO. The new virus was called SARS-CoV-2, causing COVID-19 disease.
Most infected people with SARS-CoV-2 will develop mild to moderate symptoms, as fever, tiredness or dry cough, but it can also cause severe illness, and even death, especially in people with previous conditions and in elderly people. These symptoms may appear 2-14 days after exposure to the virus.
Detection of the RNA of the virus by techniques as RT-PCR real time is important in early infection to isolate infected people and contain the outbreak. Several testing protocols and target genes for molecular diagnosis of SARS-CoV-2 infection have been issued from Health Authorities, as China CDC, Charité — Germany, or US C1 (1,2)*.
On the other hand, it is important to obtain quick results, so the use of short execution tests, that do not require the nucleic acid extraction step is of prior importance.
The Real SARS-CoV-2 and the Real SARS-CoV-2 PLUS tests are kits for the easy and sensitive detection of SARS-CoV-2 by RT-PCR real time, with protocols available that do not require nucleic acids extraction.
(1) World Health Organization, https://ww.who.int/docs/default-source/coronaviruse/protocol-v2-1.pdf, last accessed January 17, 2020
(2) Laboratory testing for coronavirus disease 2019 (COVID-19 in suspected human cases. Interim guidance 2 March 2020, WHO.
OPERON LAUNCHES ITS TEST REAL RESPIRATORY BACTERIAL PANEL 2 (BORDETELLAS)
OPERON LANZA EL TEST PARA DETECCIÓN DE SARS-COV-2 MEDIANTE PCR-REAL TIME
OPERON ANNOUNCES ITS NEW PRODUCT: S.PNEUMOSTRIP, DETECTION OF INFECTIONS CAUSED BY S.PNEUMONIAE
OPERON PCR TESTS DETECTS ALL THE NEW SARS-COV-2 VARIANTS, INCLUDING OMICRON
